Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemolizumab for the Treatment of Lichen Sclerosus
NCT07704775Phase 2Not yet recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of nemolizumab in lichen sclerosus (LS), sponsored by UT Southwestern Medical Center. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
nemolizumab
03
Conditions
lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT07704775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704775.